IMC-76

• CAT Number: I029249
• CAS Number: 98129-27-2
• Molecular Formula: C30H45NO3
• Molecular Weight: 467.69
• Purity: 98%
• Synonyms: IMC-76; IMC 76; IMC76; NSC-59276; NSC 59276; NSC59276
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (3S,5S,8S,9S,10R,13R,14R,17R)-17-[(1R)-1-(6-methoxy-2,4-dihydro-1,3-benzoxazin-3-yl)ethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
• InChI: InChI=1S/C30H45NO3/c1-19(31-17-20-15-23(33-4)6-10-28(20)34-18-31)25-8-9-26-24-7-5-21-16-22(32)11-13-29(21,2)27(24)12-14-30(25,26)3/h6,10,15,19,21-22,24-27,32H,5,7-9,11-14,16-18H2,1-4H3/t19-,21+,22+,24-,25+,26-,27+,29-,30+/m1/s1
• InChIKey: JVEDHWWWBFCUKI-JVULLFNSSA-N
• SMILES: C[C@H]([C@@H]1CC[C@H]2[C@]1(CC[C@H]3[C@@H]2CC[C@@H]4[C@]3(CC[C@@H](C4)O)C)C)N5CC6=C(C=CC(=C6)OC)OC5

IMC-76（Cat No.:I029249）is an investigational monoclonal antibody being studied for its potential therapeutic applications in cancer treatment. It is designed to target specific tumor-associated antigens or signaling pathways involved in cancer cell growth, survival, and metastasis. By binding to these targets, IMC-76 aims to inhibit tumor progression and enhance the immune system’s ability to recognize and destroy cancer cells. While preclinical and early clinical trials have shown promise, further studies are necessary to evaluate its efficacy, safety, and optimal use in combination with other therapies for various types of cancer.